Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 1, 2010Molecular Cancer TherapeuticsOpen Access

Hydroxyamidine Inhibitors of Indoleamine-2,3-dioxygenase Potently Suppress Systemic Tryptophan Catabolism and the Growth of IDO-Expressing Tumors

View Full Paper
Ask AI
Bookmark
Share

Authors

HKHolly K. KoblishWilmington UniversityMHMichael HansburyWilmington UniversityKBKevin BowmanNuvotronics (United States)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Koblish et al. (2010) studied this question.

synapsesocial.com/papers/6a7ca00765c70251ff770e4chttps://doi.org/10.1158/1535-7163.mct-09-0628
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Distinct Clinical and Prognostic Features of Infiltrating Lobular Carcinoma of the Breast: Combined Results of 15 International Breast Cancer Study Group Clinical Trials2008 · 510 citations
  2. 2Anti-CTLA4 Monoclonal Antibody Ipilimumab in the Treatment of Metastatic Melanoma: Recent Findings2008 · 28 citations
  3. 3Comparison of Gamma Interferon-Mediated Antichlamydial Defense Mechanisms in Human and Mouse Cells2005 · 127 citations
  4. 4Levo- but not dextro-1-methyl tryptophan abrogates the IDO activity of human dendritic cells2007 · 167 citations
  5. 5Expression of Indoleamine 2,3-Dioxygenase in Tumor Endothelial Cells Correlates with Long-term Survival of Patients with Renal Cell Carcinoma2007 · 179 citations